The bank estimates that weight-loss drugs, called GLP-1 agonists, could increase the nation's GDP by an extra 1% over the next decade, the equivalent of about $360 billion per year.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
